Katrin Spiegel

This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Novartis Ag. Active years: 2012-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katrin Spiegel. Retrieved from https://idiyas.com/inventor/katrin-spiegel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 2)

% Patents Active = 87.5

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 7.9

ph-index = 4

Forward Citations = 95(Granted Patents)

Company Filing History:

8 out of 3,977

Novartis Ag

patents

Years Active: 2012-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11911371 - Pyridine and pyrazine derivative for the treatment of chronic bronchitis (2024-02-27),

2. 10117858 - Pyridine and pyrazine derivative for the treatment of CF (2018-11-06),

3. RE46757 - Pyridine and pyrazine derivative for the treatment of CF (2018-03-19),

4. 9365552 - Pyridine and pyrazine derivative for the treatment of CF (2016-06-14),

5. 9034879 - Heterocyclic compounds for the treatment of CF (2015-05-19),

6. 8476269 - Pyridine and pyrazine derivative for the treatment of CF (2013-07-02),

7. 8343966 - Organic compounds (2013-01-01),

8. 8247436 - Pyridine and pyrazine derivative for the treatment of CF (2012-08-21),

Title: Katrin Spiegel: Innovator in Pharmaceutical Chemistry

Introduction

Katrin Spiegel is a prominent inventor based in Horsham, GB, known for her significant contributions to pharmaceutical chemistry. With a total of 8 patents to her name, she has made remarkable strides in developing treatments for various respiratory and gastrointestinal conditions.

Latest Patents

Among her latest patents are innovative pyridine and pyrazine derivatives aimed at treating chronic bronchitis and cystic fibrosis. These inventions focus on restoring or enhancing the function of mutant and/or wild type CFTR, addressing conditions such as chronic obstructive pulmonary disease, asthma, respiratory tract infections, lung carcinoma, xerostomia, keratoconjunctivitis, and constipation. The pharmaceutical compositions comprising these derivatives represent a significant advancement in therapeutic options for patients suffering from these ailments.

Career Highlights

Katrin currently works at Novartis AG, where she continues to push the boundaries of pharmaceutical research. Her work has not only contributed to the scientific community but has also provided new hope for patients with chronic respiratory and gastrointestinal diseases.

Collaborations

Katrin collaborates with esteemed colleagues, including Kamlesh Jagdis Bala and Lee Edwards, to further enhance the impact of her research and innovations.

Conclusion

Katrin Spiegel's work exemplifies the vital role of inventors in advancing medical science and improving patient care. Her innovative patents and dedication to research continue to make a significant difference in the field of pharmaceutical chemistry.

Profile summary based on public USPTO records.